Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct;57(Suppl 1):35-39.
doi: 10.20471/acc.2018.57.s1.04.

Role of Multiparametric Magnetic Resonance Imaging in Prostate Cancer Assessment

Igor Tomašković  1   2   3 , Matej Knežević  1 , Ivan Pezelj  1   3 , Karolina Bolanča Čulo  3 , Luka Novosel  3 , Sven Nikles  1   4 , Miroslav Tomić  1   4 , Danijel Justinić  1   4 , Josip Ninčević  3 , Matea Pirša  1   4 , Boris Ružić  1   4
Affiliations
Review

Role of Multiparametric Magnetic Resonance Imaging in Prostate Cancer Assessment

Igor Tomašković et al. Acta Clin Croat. 2018 Oct.

Abstract

Multiparametric magnetic resonance is assuming an increasingly important role in the diagnosis, initial assessment and monitoring of patients with prostate cancer. This paper offers a more complex insight into the application of magnetic resonance imaging with prostate cancer, with a current literature overview. The focus is on the problem of initial prostate cancer evaluation which strongly affects further decision-making and therapeutic interventions. Clinical suggestions based on the current guidelines are also offered.

Keywords: Cancer staging; Diagnostic imaging; Guidelines; Magnetic resonance; Prostate cancer; Radical prostatectomy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Multiparametric magnet shows a localized index lesion limited within the prostate. Pathological finding after radical prostatectomy confirms localized cancer (index lesion), Gleason score 3+4, (cT2 stage) and one smaller, peripheral indolent lesion. (Courtesy of: Assist. Prof. Monika Ulamec, MD and Karolina Bolanča, MD, Sestre milosrdnice University Hospital Center Zagreb).
See this image and copyright information in PMC

References

    1. Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, et al. Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA. 2015;313(4):390–7. 10.1001/jama.2014.17942 - DOI - PMC - PubMed
    1. Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012;367(3):203–13. 10.1056/NEJMoa1113162 - DOI - PMC - PubMed
    1. Rud E, Klotz D, Rennesund K, Baco E, Johansen T, Diep L, et al. Preoperative magnetic resonance imaging for detecting uni-and bilateral extraprostatic disease in patients with prostate cancer. World J Urol. 2015;33(7):1015–21. 10.1007/s00345-014-1362-x - DOI - PMC - PubMed
    1. Fulgham PF, Rukstalis DB, Turkbey IB, Rubenstein JN, Taneja S, Carroll PR, et al. AUA Standard Operating Procedure for MRI of the Prostate. J Urol. 2017;198(4):832–8. 10.1016/j.juro.2017.04.101 - DOI - PMC - PubMed
    1. Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017;71(4):618–29. 10.1016/j.eururo.2016.08.003 - DOI - PubMed

LinkOut - more resources